Allen Cato
Corporate Officer/Principal chez VISTAGEN THERAPEUTICS, INC.
Profil
Allen Cato was the founder of Cato Research LLC, where he served as the Chief Executive Officer starting in 1998.
Dr. Cato is also the founder of Cato BioVentures.
Currently, Dr. Cato holds the position of Chief Executive & Medical Officer at Cancer Advances, Inc. and Senior Vice President-Development Operations at Vistagen Therapeutics, Inc. Dr. Cato's former positions include Chairman at Hemodynamic Therapeutics, Inc., Director at Echo Therapeutics, Inc., Director at Nutritional Restart Pharmaceutical LP, Advisor at VistaGen Therapeutics, Inc., and President at Advanced Pain Remedies, Inc.
Postes actifs de Allen Cato
| Sociétés | Poste | Début |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Cato BioVentures
 Cato BioVentures Investment ManagersFinance Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina. | Fondateur | 05/01/2011 |
Cancer Advances, Inc.
 Cancer Advances, Inc. BiotechnologyHealth Technology Cancer Advances, Inc. develops treatment of gastrointestinal cancers. It also develops variety of immunomodulators which includes adaptive T-cells, therapeutic vaccines, and monoclonal antibodies for the treatment of gastric and pancreatic cancer. The company was founded in 2008 and is headquartered in Durham, NC. | Directeur Général | - |
Anciens postes connus de Allen Cato
| Sociétés | Poste | Fin |
|---|---|---|
VistaGen Therapeutics, Inc. /Old/
 VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions. | Corporate Officer/Principal | 10/06/2011 |
Nutritional Restart Pharmaceutical LP
 Nutritional Restart Pharmaceutical LP Pharmaceuticals: MajorHealth Technology Nutritional Restart Pharmaceutical LP developed pharmaceutical products. The company was founded in 1996 and was headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
| ECHO THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
Hemodynamic Therapeutics, Inc.
 Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC. | Président | - |
Advanced Pain Remedies, Inc.
 Advanced Pain Remedies, Inc. BiotechnologyHealth Technology Advanced Pain Remedies, Inc. operates as a biotechnology company. It focuses on treating intractable chronic pain. The company was founded on October 21, 2010 and is headquartered in Durham, NC. | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VISTAGEN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Cato Research LLC operates as an international regulatory and clinical contract research organization. It offers clinical strategy, clinical trial services, data management and biostatistics, medical and pharmacovigilance, medical writing, pharmacokinetics, preclinical/nonclinical services, project management, quality assurance, and regulatory affairs. The company was founded by Allen Cato and Lynda Sutton in 1988 and is headquartered in Durham, NC. | Commercial Services |
VistaGen Therapeutics, Inc. /Old/
VistaGen Therapeutics, Inc. /Old/ BiotechnologyHealth Technology VistaGen Therapeutics, Inc. is a South San Francisco-based biotechnology company that focuses on providing clinically relevant, commercially scalable, human stem cell biology-based screening systems capable of predicting the safety and efficacy of new drugs in ways never before possible. VistaGen's Clinical Trials in a Test Tube platform is designed to generate predictive information that results in reduced probability of clinical trial drug failures, especially failures associated with heart and liver toxicity. VistaGen expects its new-generation stem cell-based human systems biology platform to enhance dramatically the pharmaceutical industry's ability to deliver innovative drugs for some of the world's most challenging diseases and conditions. | Health Technology |
Cato BioVentures
Cato BioVentures Investment ManagersFinance Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina. | Finance |
Hemodynamic Therapeutics, Inc.
Hemodynamic Therapeutics, Inc. BiotechnologyHealth Technology Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC. | Health Technology |
Echo Therapeutics, Inc.
 Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |
Advanced Pain Remedies, Inc.
Advanced Pain Remedies, Inc. BiotechnologyHealth Technology Advanced Pain Remedies, Inc. operates as a biotechnology company. It focuses on treating intractable chronic pain. The company was founded on October 21, 2010 and is headquartered in Durham, NC. | Health Technology |
Cancer Advances, Inc.
Cancer Advances, Inc. BiotechnologyHealth Technology Cancer Advances, Inc. develops treatment of gastrointestinal cancers. It also develops variety of immunomodulators which includes adaptive T-cells, therapeutic vaccines, and monoclonal antibodies for the treatment of gastric and pancreatic cancer. The company was founded in 2008 and is headquartered in Durham, NC. | Health Technology |
Nutritional Restart Pharmaceutical LP
Nutritional Restart Pharmaceutical LP Pharmaceuticals: MajorHealth Technology Nutritional Restart Pharmaceutical LP developed pharmaceutical products. The company was founded in 1996 and was headquartered in Durham, NC. | Health Technology |
